Diagnosis andtreatment of hypothyroidism: current principles (a review)


如何引用文章

全文:

参考

  1. Canaris G. J., Manowitz N. R., Mayor G., Ridgway E. G. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000; 160: 526-534.
  2. Parle J. V., Franklyn J. A., Cross K. W. et al. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment (see comments). Br. J. Gen. Pract. 1993; 43: 107-109.
  3. Vanderpump M., Tunbridge W. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002; 12: 839-847.
  4. Левченко И. А., Фадеев В. В. Субклинический гипотиреоз. Пробл. эндокринол. 2002; 48 (2): 13-22.
  5. Ladenson P. W., Singer P. A., Ain К. В. et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch. Intern. Med. 2000; 160: 1573-1575.
  6. Danese M. D., Ladenson P. W., Meinert С L., Powe N. R. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 2000; 85 (9): 2993-3001.
  7. O'Reilly D. Thyroid function teststime for a reassessment. Br. Med. J. 2000; 320: 1332-1334.
  8. Фадеев В. В., Лесникова С. В. Аутоиммунные заболевания щитовидной железы и беременность. Пробл. эндокринол. 2003; 49 (2): 23-31.
  9. Peterson К., Bengtsson С, Lapidus L. et al. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch. Intern. Med. 1990; 150: 2077-2081.
  10. Saravanan P., Chau W. F., Roberts N. et al. Psychological wellbeing in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 2002; 57: 577-585.
  11. Фадеев В. В., Мельниченко Г. А. Гипотиреоз: (Руководство для врачей). М.: РКИ Северо пресс; 2002.
  12. International thyroid testing guidelines. National academy of clinical biochemistry. Los Angeles; 2001. ( <http://>www.nacb.org/Thyroid_LMPG.htm <http://www.nacb.org/Thyroid_LMPG.htm>).
  13. Vanderpump M. P., Tunbridge W. M., French J. M. et al. The incidence of thyroid disorders in the community: a twenty-year followup of the Whickham Survey. Clin Endocrinol. 1995; 43 (1): 55-68.
  14. Hollowed J. G., Staehling N. W., Flanders W. D. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002; 87 (2): 489-499.
  15. Bunevicius R., Kazanavicius G., Zalinkevicius R., Prange A. J. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N. Engl. J. Med. 1999; 340: 424-429.
  16. Barakate M. S., Agarwal G., Reeve T. S. et al. Total thyroidectomy is now the preferred option for the surgical management of Graves' disease. Aust. N. Z. J. Surg. 2002; 72: 321-324.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##